Complete Revascularisation 2022: On-Demand
Published: 03 May 2022
-
Views:
26158
-
Likes:
7
Overview
Full programme
-
Views:
26158
-
Likes:
7
Summary of Day One: Adrian Banning
- CT Guided Intervention and 3D Reconstruction: Carlos Collet
- A Walkthrough Zero - or Minimal Contrast PCI: Ziad Ali
- Live Cases: St George's Hospital - James Spratt, Claudia Cosgrove. Aarhus University Hospital - Lars Jakobsen, Niels Holm, Christian Juhl Terkelsen
- Sex Differences in Presentation, Treatment, Outcome: Clare Appleby
- Summary of Day One: Adrian Banning
Overview
Millbrook Medical Conferences, in association with Abbott and Radcliffe Cardiology, proudly introduce the 6th annual CORE meeting, brought to you live and in person from the Royal College of Physicians, London.
CORE 2022 assembles world renowned experts to discuss and demonstrate how we can optimise PCI outcomes, together as a community. Innovative lectures and live cases address the appropriate treatment pathway for patients in 2022. We explore how to further improve patient outcomes by looking at the latest clinical evidence, cutting-edge techniques and beyond the intervention.

More from this programme
Part 1
CORE 2022 - Day 1: Morning - Imaging and Physiology
Part 2
CORE 2022 - Day 1: Afternoon - Pre-procedural Planning
Part 3
CORE 2022 - Day 2: Morning - Challenges in Complex PCI
Part 4
CORE 2022 - Day 2: Afternoon - Beyond Intervention
Faculty Biographies
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.